The Middle EAST Polymerase Chain Reaction (PCR) Market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.5 billion by 2034, registering a CAGR of 7.5%. This growth trajectory is underpinned by the increasing demand for rapid and accurate diagnostic techniques, particularly in the context of rising infectious diseases and genetic disorders. The adoption of PCR technology in...